Last reviewed · How we verify

NCT07324278

Hybrid Stroke Rehab With Mirror Priming

Recruiting now NA Last updated 7 January 2026
What this trial tests

NA trial testing Mirror priming in Cardiovascular Diseases in 81 participants. Currently enrolling.

Timeline
30 December 2025
Primary endpoint
31 December 2030
31 December 2030

Quick facts

Lead sponsorI-Shou University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment81
Start date30 December 2025
Primary completion31 December 2030
Estimated completion31 December 2030
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

I-Shou University

Who can join

Adults 20 to 80, any sex, with Cardiovascular Diseases or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial aims to examine the effects of enhanced mirror priming, overcoming the limitations of traditional mirror therapy, to achieve optimization and personalized intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other I-Shou University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07324278.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing